Insulin reverses endothelial dysfunction via A2B adenosine receptor activation in human umbilical vein endothelium from late-onset preeclampsia

Simple item page
dc.catalogadorpau
dc.contributor.authorSalsoso Rodríguez, M. Rocío
dc.contributor.authorLeiva Mendoza, Andrea Alejandra
dc.contributor.authorPardo, Fabián
dc.contributor.authorChiarello, Indira
dc.contributor.authorFarías Jofré, Marcelo Enrique
dc.contributor.authorVázquez, Carmen
dc.contributor.authorSobrevía Luarte, Luis Alberto
dc.date.accessioned2023-05-18T19:49:46Z
dc.date.available2023-05-18T19:49:46Z
dc.date.issued2016
dc.description.abstractPreeclampsia courses with endothelial and insulin resistance. Insulin dilates umbilical vein requiring A2A adenosine receptor (A2AAR) activation in normal pregnancies; however, whether A2AAR are involved in late-onset preeclampsia (LOPE)-reduced insulin dilation is unknown. LOPE increases maternal and foetal plasma adenosine and A2BAR expression in human umbilical vein endothelial cells (HUVECs). A2BAR involvement and insulin effect on the foe- toplacental vascular function in LOPE is unknown. Aim: To evaluate A2AAR and A2BAR involvement on insulin effect on endothelial function in umbilical veins and HUVECs from LOPE. Methods: Protein abundance (total and phosphorylated) of p44/42mapk, protein kinase B/Akt (Akt), endothelial nitric oxide synthase (eNOS) were detected by Western blot. Assays were in the absence or presence (8 h) of 1 nM insulin, 30 nM CGS21680 (A2AAR agonist), 10 nM ZM241385 (A2AAR antagonist), 0.1 nM BAY606583 (A2BAR agonist), or 30 nM MRS1754 (A2BAR antago- nist). Vascular response to insulin (0.1–1000 nM, 5 min) was mea- sured in preconstricted umbilical vein rings (wire myography) in the absence or presence of adenosine (1 mM) and/or A2AAR and A2BAR antagonists. L-Citrulline level was measured by HPLC in the absence or presence (8 h) of NG-nitro- L-arginine methyl ester (100 lM) in HUVECs. Results: Insulin increased Akt (1.3 to 0.1 fold), p44/42mapk (1.2 to 0.1 fold), Ser1177 eNOS phosphorylation (1.2 to 0.01 fold), and total eNOS protein abundance (1.5 to 0.1 fold) in HUVECs from normal pregnancies. A2AAR and A2BAR activation enhanced insulin effect only on Akt (1.6 to 0.1 fold). LOPE only increased Ser1177 eNOS phos- phorylation and total eNOS protein abundance (2.2 to 0.9 and 1.4 to 0.2 fold, respectively). Insulin blocked LOPE-increased Ser1177 eNOS phosphorylation. A2AAR and A2BAR activation did not change insu- lin effect on Akt and p44/42mapk, whereas A2AAR antagonist reversed insulin-decreased Ser1177 eNOS phosphorylation and increased total eNOS protein abundance in LOPE. Insulin dilation of umbilical veins from normal pregnancies was lower (14 to 2%, max- imal relaxation (Rmax)) in the presence of A2AAR. LOPE reduced insulin dilation (18 to 3% Rmax), which was restored by A2AAR antagonists. Insulin increased L-citrulline content (5.3 to 0.3 fold), a phenomenon blocked by A2AAR and A2BAR antagonists in normal pregnancies. LOPE increased L-citrulline content, which was unal- tered by insulin in absence of A2AAR and A2BAR antagonists. However, insulin increased L-citrulline content in the presence of A2AAR antagonists, but blocked by A2BAR antagonists in LOPE. Conclusion: The reduced foetoplacental vascular response to insu- lin in LOPE involves A2AAR activation, a phenomenon counteracted by A2BAR activation.
dc.format.extent2 páginas
dc.fuente.origenORCID
dc.identifier.doi10.1016/j.preghy.2016.08.147
dc.identifier.issn2210-7789
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2210778916302185
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/67118
dc.information.autorucEscuela de medicina; Salsoso Rodríguez, M. Rocío; 0000-0002-8218-1882; 225406
dc.information.autorucEscuela de medicina; Leiva Mendoza, Andrea Alejandra; 0000-0001-7349-5380; 3362
dc.information.autorucFacultad de ciencias biológicas; Leiva Mendoza, Andrea Alejandra; 0000-0001-7349-5380; 3362
dc.information.autorucEscuela de medicina; Pardo, Fabián; 0000-0002-6994-0418; 1004392
dc.information.autorucEscuela de medicina; Farías Jofré, Marcelo Enrique; 0000-0003-0473-2295; 12286
dc.information.autorucEscuela de medicina; Sobrevía Luarte, Luis Alberto; 0000-0001-5802-2243; 1002656
dc.issue.numero65
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final210
dc.pagina.inicio209
dc.revistaPregnancy hypertension
dc.rightsacceso restringido
dc.titleInsulin reverses endothelial dysfunction via A2B adenosine receptor activation in human umbilical vein endothelium from late-onset preeclampsia
dc.typeartículo
dc.volumen6
sipa.codpersvinculados225406
sipa.codpersvinculados3362
sipa.codpersvinculados1004392
sipa.codpersvinculados12286
sipa.codpersvinculados1002656
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
65. Insulin reverses endothelial dysfunction via A2B adenosine receptor activation in human umbilical vein endothelium from late-onset preeclampsia.pdf
Size:
3.65 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas